Many Americans still in the dark about antibiotic resistance
November 13, 2012 by Amanda Gardner, Healthday Reporter in Diseases, Conditions, Syndromes
Poll found misconceptions linger about what it means, how it happens.
(HealthDay)—Americans are not as smart about antibiotics and antibiotic resistance as they should be, a new poll shows.
For instance, although almost 90 percent of Americans know that antibiotics are effective for treating bacterial infections, more than a third also erroneously believed the drugs can fight viral infections such as the common cold or the flu.
"It's a common misperception that antibiotics can cure the common cold, and unnecessary overuse of antibiotics for illnesses like colds is dumping fuel on a wildfire of resistance," said Dr. Lauri Hicks, medical director of the "Get Smart: Know When Antibiotics Work" program at the U.S. Centers for Disease Control and Prevention.
The number of antibiotic-resistant "superbugs" is soaring. In 2005, almost 370,000 Americans were hospitalized with methicillin-resistant Staphylococcus aureus (MRSA), up from only about 2,000 in 1993. MRSA and other drug-resistant infections kill about 60,000 people every year in the United States, and add up to untold days spent in the hospital and billions of dollars in health care costs, according to the CDC.
The new poll, which surveyed 1,000 adults by phone and more in focus groups, was conducted by The Pew Charitable Trusts in collaboration with the CDC and is being released as part of the CDC's "Get Smart About Antibiotics Week."
Only 25 percent of respondents had heard "a great deal" about antibiotic resistance, one-third had heard a "fair amount" and a full 41 percent had heard very little or nothing at all.
But even among those who had heard about antibiotic resistance, many misperceptions surfaced during the course of the survey work.
For instance, even though the majority of respondents knew that unnecessary use of antibiotics could harm their health, less than half realized that this could also harm other members of the community.
Many participants wrongly believed that individuals build up tolerance to antibiotics, when it is the bacteria themselves that become resistant.
"They put it on the person rather than on the bacterium," said Jay Campbell, vice president of Hart Research Associates, which conducted the research. "It's not entirely clear to people that there's a huge community impact."
Eighty-six percent of Americans know that the full prescribed course of antibiotics should be finished even when symptoms have vanished, but many said they did not actually abide by this rule.
One expert said the news is not all bad, however.
"There is also good news," said Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics & Policy. The data indicates that antibiotic prescribing across the United States has dropped by 17 percent since 1999, even if the reductions have not been uniform. States like Mississippi, Louisiana, Alabama and West Virginia have had the most modest declines or slight increases in antibiotic prescribing while states like Alaska, Hawaii and California have had significant declines in prescribing, Laxminarayan noted.
Still, there are clear strategies to help outwit the problem of resistance.
"The bad news is that antibiotic-resistant infections are increasing at an alarming rate and we are running out of treatment options for many infections," said Hicks. "The good news is that there are action steps that each one of us can take to stop spread of resistant infections."
First and foremost, consumers and doctors need to understand that antibiotics should only be used when they are really needed, she said.
When they are prescribed, people should use them responsibly, taking them exactly as directed, practicing good hygiene (especially frequent and thorough hand washing) and getting recommended vaccines, Hicks added.
This is especially important in light of the fact that few new antibiotics are coming down the pipeline.
"Finding safe, new antibiotics isn't easy, and new drug development is not keeping pace with the emergence of resistance," said Hicks. "We need to use antibiotics wisely, no matter what tools are in the pipeline."
More information: Find out how much you know about antibiotics by taking the Antibiotics IQ test.
Copyright © 2012 HealthDay. All rights reserved.
-
Drug-resistant infections: A new epidemic, and what you can do to help
Nov 10, 2011 |
not rated yet |
0
-
Health experts urge supermarket pharmacies to 'get smart' about free antibiotics
Feb 25, 2009 |
not rated yet |
0
-
CDC: Doctors prescribing fewer antibiotics to kids
Sep 01, 2011 |
not rated yet |
0
-
Study examines role of seasonal prescribing changes in antibiotic resistance
Jul 02, 2012 |
not rated yet |
0
-
Free antibiotics: The wrong prescription for cold and flu season
Jan 16, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Researchers find genetic risk factor for pulmonary fibrosis
A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibros ...
Diseases, Conditions, Syndromes
10 hours ago |
not rated yet |
0
Biomarkers discovered for inflammatory bowel disease
Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...
Diseases, Conditions, Syndromes
10 hours ago |
5 / 5 (1) |
0
CDC says high number of public pools contain microbes
(HealthDay)—Three-quarters of public schools in the metro Atlanta area contain microbes, including bacteria indicating the presence of fecal matter, according to research published in the May 17 issue of ...
Diseases, Conditions, Syndromes
11 hours ago |
not rated yet |
0
Study examines outbreak of spinal infections in Michigan
(HealthDay)—Factors such as increased case finding may explain why Michigan had half of the total spinal infections associated with contaminated methylprednisolone acetate in the recent fungal meningitis ...
Diseases, Conditions, Syndromes
11 hours ago |
not rated yet |
0
World not ready for mass flu outbreak, WHO says
The world is unprepared for a massive virus outbreak, the deputy chief of the World Health Organization warned Tuesday, amid fears that H7N9 bird flu striking China could morph into a form that spreads easily among people.
Diseases, Conditions, Syndromes
12 hours ago |
not rated yet |
0
Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens
Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...